Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer
Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer is a paper indexed in PICO Portal from OpenAlex.
How many citations does Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer have?
Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer has 86 citations in the OpenAlex counts PICO Portal stores.
When was Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer published?
Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer has 2022 year in the PICO Portal index.
What is the open-access status of Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer?
Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer has gold oa status in the PICO Portal index.
What is the DOI of Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer?
The DOI for Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer is on the source record.
What is the PMID of Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer?
The PMID for Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer is on the source record.
What is the OpenAlex record for Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer?
The OpenAlex for Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer is on the source record.